Oppenheimer analyst Kevin DeGeeter maintained a Buy rating on Mediwound (MDWD) today and set a price target of $7.00.
The post Mediwound (MDWD) Gets a Buy Rating from Oppenheimer appeared first on Smarter Analyst.
Oppenheimer analyst Kevin DeGeeter maintained a Buy rating on Mediwound (MDWD) today ...

https://www.smarteranalyst.com/new-blurbs/mediwound-mdwd-gets-a-buy-rating-from-oppenheimer-3/

#SmarterAnalyst